Basic Information
Basic information for LINC01278-219-12aa
Peptide Name LINC01278-219-12aa
Genome Position chrX:63516910-63516928,63561059-63561075[-]
Species Human
Peptide Sequence MAVTAWYGRKFS
Peptide Length 12
Unique No (LINC01278-201-12aa,LINC01278-205-12aa,LINC01278-209-12aa,LINC01278-210-12aa,LINC01278-211-12aa,LINC01278-215-12aa,LINC01278-218-12aa-2,LINC01278-220-12aa,LINC01278-221-12aa,LINC01278-222-12aa,LINC01278-223-12aa,LINC01278-224-12aa,LINC01278-225-12aa,LINC01278-226-12aa,LINC01278-228-12aa,LINC01278-229-12aa,LINC01278-230-12aa,LINC01278-233-12aa,LINC01278-234-12aa,LINC01278-239-12aa)
Grand Average of Hydropathicity 0
Relative Molecular Mass 1614.85
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000662156;LINC01278-219
Transcript Length 3088
Coding Ability 0.4456
DNA Sequence Corresponding to Peptide ATGGCGGTGACTGCGTGGTATGGAAGAAAATTCAGC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :